The endocrine and paracrine control of menstruation

Molecular and Cellular Endocrinology

Volumn 358, Issue 2, 2012, Pages 197-207

  Henriet, Patrick ^a   Gaide Chevronnay, Héloïse P ^a   Marbaix, Etienne ^a  

^a DE DUVE INSTITUTE   (Belgium)

Author keywords

Chemokines; Cytokines; Endometrium; Matrix metalloproteinases; Progesterone; Prostaglandins

Indexed keywords

CASPASE; CHEMOKINE; CYTOKINE; ENDOTHELIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INTERLEUKIN 1ALPHA; LEFT RIGHT DETERMINATION FACTOR; LEFT RIGHT DETERMINATION FACTOR 2; LEVONORGESTREL; LYSOSOME ENZYME; MATRIX METALLOPROTEINASE; MICRORNA; PLASMIN; PLASMINOGEN; PROGESTERONE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; DECIDUALIZATION; EARLY SECRETORY PHASE; ENDOMETRIOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; HORMONAL REGULATION; HUMAN; INFLAMMATORY CELL; LATE SECRETORY PHASE; LYSOSOME; MENSTRUAL CYCLE; MENSTRUATION; NONHUMAN; PARACRINE SIGNALING; PARADOXICAL DRUG REACTION; PRIORITY JOURNAL; PROLIFERATIVE PHASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; UTERUS BLEEDING;

DECIDUA; ENDOCRINE SYSTEM; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MENSTRUAL CYCLE; MENSTRUATION; PARACRINE COMMUNICATION;

EID: 84861529541     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.042     Document Type: Review

References (180)

1. Abe H., Shibata M.A., Otsuki Y. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells. Mol. Hum. Reprod. 2006, 12(9):535-541.
2. Andersson J.K., Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br. J. Obstet. Gynaecol. 1990, 97(8):690-694.
3. Atasoy P., Bozdogan O., Erekul S., Bozdogan N., Bayram M. Fas-mediated pathway and apoptosis in normal, hyperplastic, and neoplastic endometrium. Gynecol. Oncol. 2003, 91(2):309-317.
4. Bamberger A.M., Bamberger C.M., Gellersen B., Schulte H.M. Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc. Natl. Acad. Sci. USA 1996, 93(12):6169-6174.
5. Bamberger A.M., Milde-Langosch K., Loning T., Bamberger C.M. The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium. J. Clin. Endocrinol. Metab. 2001, 86(10):5071-5074.
6. Bartelmez G.W. The human uterine mucous membrane during menstruation. Am. J. Obstet. Gynecol. 1931, 21:623-643.
7. Battersby S., Critchley H.O., de Brum-Fernandes A.J., Jabbour H.N. Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle. Reproduction 2004, 127(1):79-86.
8. Berton A., Selvais C., Lemoine P., Henriet P., Courtoy P.J., Marbaix E., Emonard H. Binding of matrilysin-1 to human epithelial cells promotes its activity. Cell. Mol. Life Sci. 2007, 64(5):610-620.
9. Bonney R.C., Scanlon M.J., Jones D.L., Reed M.J., James V.H. Adrenal androgen concentrations in endometrium and plasma during the menstrual cycle. J. Endocrinol. 1984, 101(2):181-188.
10. Brar A.K., Handwerger S., Kessler C.A., Aronow B.J. Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol. Genomics 2001, 7(2):135-148.
11. Brenner R.M., Nayak N.R., Slayden O.D., Critchley H.O., Kelly R.W. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann. NY Acad. Sci. 2002, 955:60-74.
12. Brosens, J.J., Parker, M.G., McIndoe, A., Pijnenborg, R., Brosens, I.A., 2009. A role for menstruation in preconditioning the uterus for successful pregnancy. Am. J. Obstet. Gynecol. 200(6), 615 e1-615 e6.
13. Bruner K.L., Eisenberg E., Gorstein F., Osteen K.G. Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 1999, 64(9):648-653.
14. Bruner K.L., Rodgers W.H., Gold L.I., Korc M., Hargrove J.T., Matrisian L.M., Osteen K.G. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natl. Acad. Sci. USA 1995, 92(16):7362-7366.
15. Burney R.O., Hamilton A.E., Aghajanova L., Vo K.C., Nezhat C.N., Lessey B.A., Giudice L.C. MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol. Hum. Reprod. 2009, 15(10):625-631.
16. Burton K.A., Henderson T.A., Hillier S.G., Mason J.I., Habib F., Brenner R.M., Critchley H.O. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum. Reprod. 2003, 18(12):2610-2617.
17. Camier B., Hedon B., Rochefort H., Maudelonde T. Endometrial cathepsin D immunostaining throughout ovulatory and anovulatory menstrual cycles. Hum. Reprod. 1996, 11(2):392-397.
18. Casey M.L., MacDonald P.C., Andersson S. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J. Clin. Invest. 1994, 94(5):2135-2141.
19. Casslen, B., Sandberg, T., Gustavsson, B., Willen, R., and Nilbert, M., 1998. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1. Biol. Reprod. 58(6), 1343-1350.
20. Casslen B., Urano S., Lecander I., Ny T. Plasminogen activators in the human endometrium, cellular origin and hormonal regulation. Blood Coagul. Fibrinolysis 1992, 3(2):133-138.
21. Catalano R.D., Critchley H.O., Heikinheimo O., Baird D.T., Hapangama D., Sherwin J.R., Charnock-Jones D.S., Smith S.K., Sharkey A.M. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol. Hum. Reprod. 2007, 13(9):641-654.
22. Chegini N., Ma C., Roberts M., Williams R.S., Ripps B.A. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. J. Reprod. Immunol. 2002, 56(1-2):93-110.
23. Clark I.M., Swingler T.E., Sampieri C.L., Edwards D.R. The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 2008, 40(6-7):1362-1378.
24. Cloke B., Huhtinen K., Fusi L., Kajihara T., Yliheikkila M., Ho K.K., Teklenburg G., Lavery S., Jones M.C., Trew G., Kim J.J., Lam E.W., Cartwright J.E., Poutanen M., Brosens J.J. The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium. Endocrinology 2008, 149(9):4462-4474.
25. Colditz I.G. Effect of exogenous prostaglandin E2 and actinomycin D on plasma leakage induced by neutrophil-activating peptide-1/interleukin-8. Immunol. Cell Biol. 1990, 68:397-403.
26. Collett G.P., Kohnen G., Campbell S., Davenport A.P., Jeffers M.D., Cameron I.T. Localization of endothelin receptors in human uterus throughout the menstrual cycle. Mol. Hum. Reprod. 1996, 2(6):439-444.
27. Condon J.C., Hardy D.B., Kovaric K., Mendelson C.R. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol. Endocrinol. 2006, 20(4):764-775.
28. Conneely O.M., Mulac-Jericevic B., Lydon J.P. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 2003, 68(10-13):771-778.
29. Cornet P.B., Galant C., Eeckhout Y., Courtoy P.J., Marbaix E., Henriet P. Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. J. Clin. Endocrinol. Metab. 2005, 90(2):1001-1011.
30. Cornet, P.B., Picquet, C., Lemoine, P., Osteen, K.G., Bruner-Tran, K.L., Tabibzadeh, S., Courtoy, P.J., Eeckhout, Y., Marbaix, E., and Henriet, P., 2002. Regulation and function of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progesterone, and effect on matrix metalloprotineases. J. Biol. Chem. 277(45), 42496-42504.
31. Cornillie F., Brosens I., Belsey E.M., Marbaix E., Baudhuin P., Courtoy P.J. Lysosomal enzymes in the human endometrium: a biochemical study in untreated and levonorgestrel-treated women. Contraception 1991, 43(4):387-400.
32. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 1999, 20(3):358-417.
33. Critchley H.O., Jones R.L., Lea R.G., Drudy T.A., Kelly R.W., Williams A.R., Baird D.T. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J. Clin. Endocrinol. Metab. 1999, 84(1):240-248.
34. Critchley H.O., Saunders P.T. Hormone receptor dynamics in a receptive human endometrium. Reprod. Sci. 2009, 16(2):191-199.
35. Dahmoun M., Boman K., Cajander S., Westin P., Backstrom T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J. Clin. Endocrinol. Metab. 1999, 84(5):1737-1743.
36. Dawood M.Y., Saxena B.B. Plasma testosterone and dihydrotestosterone in ovulatory and anovulatory cycles. Am. J. Obstet. Gynecol. 1976, 126(4):430-435.
37. Dunn C.L., Critchley H.O., Kelly R.W. IL-15 regulation in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 2002, 87(4):1898-1901.
38. Eeckhout, Y., Vaes, G., 1977. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem. J. 166(1), 21-31.
39. Emonard, H., Bellon, G., Troeberg, L., Berton, A., Robinet, A., Henriet, P., Marbaix, E., Kirkegaard, K., Patthy, L., Eeckhout, Y., Nagase, H., Hornebeck, W., Courtoy, P.J., 2004. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 279(52), 54944-54951.
40. Fan X., Krieg S., Kuo C.J., Wiegand S.J., Rabinovitch M., Druzin M.L., Brenner R.M., Giudice L.C., Nayak N.R. VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J. 2008, 22(10):3571-3580.
41. Federman D.D. The biology of human sex differences. N. Engl. J. Med. 2006, 354(14):1507-1514.
42. Felx M., Guyot M.C., Isler M., Turcotte R.E., Doyon J., Khatib A.M., Leclerc S., Moreau A., Moldovan F. Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin. Sci. (Lond.) 2006, 110(6):645-654.
43. Ferenczy, A., 1976a. Studies on the cytodynamics of human endometrial regeneration. I: Scanning electron microscopy. Am. J. Obstet. Gynecol. 124(1), 64-74.
44. Ferenczy, A., 1976b. Studies on the cytodynamics of human endometrial regeneration. II: Transmission electron microscopy and histochemistry. Am. J. Obstet. Gynecol. 124(6), 582-595.
45. Fernandes M.S., Pierron V., Michalovich D., Astle S., Thornton S., Peltoketo H., Lam E.W., Gellersen B., Huhtaniemi I., Allen J., Brosens J.J. Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues. J. Endocrinol. 2005, 187(1):89-101.
46. Finn C.A. Menstruation: a nonadaptive consequence of uterine evolution. Q. Rev. Biol. 1998, 73(2):163-173.
47. Franchi A., Zaret J., Zhang X., Bocca S., Oehninger S. Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. Mol. Hum. Reprod. 2008, 14(7):413-421.
48. Freitas S., Meduri G., Le Nestour E., Bausero P., Perrot-Applanat M. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol. Reprod. 1999, 61(4):1070-1082.
49. Gaide Chevronnay H.P., Cornet P.B., Delvaux D., Lemoine P., Courtoy P.J., Henriet P., Marbaix E. Opposite regulation of transforming growth factors-beta2 and -beta3 expression in the human endometrium. Endocrinology 2008, 149(3):1015-1025.
50. Gaide Chevronnay H.P., Galant C., Lemoine P., Courtoy P.J., Marbaix E., Henriet P. Spatiotemporal coupling of focal extracellular matrix degradation and reconstruction in the menstrual human endometrium. Endocrinology 2009, 150(11):5094-5105.
51. Gaide Chevronnay H.P., Lemoine P., Courtoy P.J., Marbaix E., Henriet P. Ovarian steroids, mitogen-activated protein kinases, and/or aspartic proteinases cooperate to control endometrial remodeling by regulating gene expression in the stroma and glands. Endocrinology 2010, 151(9):4515-4526.
52. Galant C., Vekemans M., Lemoine P., Kokorine I., Twagirayezu P., Henriet P., Picquet C., Rigot V., Eeckhout Y., Courtoy P.J., Marbaix E. Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception. J. Clin. Endocrinol. Metab. 2000, 85(12):4827-4834.
53. Gannon B.J., Carati C.J., Verco C.J. Endometrial perfusion across the normal human menstrual cycle assessed by laser Doppler fluxmetry. Hum. Reprod. 1997, 12(1):132-139.
54. Garry R., Hart R., Karthigasu K.A., Burke C. A re-appraisal of the morphological changes within the endometrium during menstruation: a hysteroscopic, histological and scanning electron microscopic study. Hum. Reprod. 2009, 24(6):1393-1401.
55. Gashaw I., Stiller S., Boing C., Kimmig R., Winterhager E. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium. Endocrinology 2008, 149(5):2261-2269.
56. Gellersen B., Fernandes M.S., Brosens J.J. Non-genomic progesterone actions in female reproduction. Hum. Reprod. Update 2009, 15(1):119-138.
57. Germeyer A., Sharkey A.M., Prasadajudio M., Sherwin R., Moffett A., Bieback K., Clausmeyer S., Masters L., Popovici R.M., Hess A.P., Strowitzki T., von Wolff M. Paracrine effects of uterine leucocytes on gene expression of human uterine stromal fibroblasts. Mol. Hum. Reprod. 2009, 15(1):39-48.
58. Giangrande P.H., Kimbrel E.A., Edwards D.P., McDonnell D.P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol. Cell. Biol. 2000, 20(9):3102-3115.
59. Giangrande P.H., Pollio G., McDonnell D.P. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J. Biol. Chem. 1997, 272(52):32889-32900.
60. Goebelsmann U., Arce J.J., Thorneycroft I.H., Mishell D.R. Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration. Am. J. Obstet. Gynecol. 1974, 119(4):445-452.
61. Goffin F., Munaut C., Frankenne F., Perrier D'Hauterive S., Beliard A., Fridman V., Nervo P., Colige A., Foidart J.M. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol. Reprod. 2003, 69(3):976-984.
62. Grinius L., Kessler C., Schroeder J., Handwerger S. Forkhead transcription factor FOXO1A is critical for induction of human decidualization. J. Endocrinol. 2006, 189(1):179-187.
63. He S., Prasanna G., Yorio T. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest. Ophthalmol. Vis. Sci. 2007, 48(8):3737-3745.
64. Henderson T.A., Saunders P.T., Moffett-King A., Groome N.P., Critchley H.O. Steroid receptor expression in uterine natural killer cells. J. Clin. Endocrinol. Metab. 2003, 88(1):440-449.
65. Henzl M.R., Smith R.E., Boost G., Tyler E.T. Lysosomal concept of menstrual bleeding in humans. J. Clin. Endocrinol. Metab. 1972, 34(5):860-875.
66. Herz J., Strickland D.K. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 2001, 108(6):779-784.
67. Horie K., Takakura K., Fujiwara H., Suginami H., Liao S., Mori T. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum. Reprod. 1992, 7(2):184-190.
68. Igarashi T., Konno R., Okamoto S., Moriya T., Satoh S., Yajima A. Involvement of granule-mediated apoptosis in the cyclic changes of the normal human endometrium. Tohoku J. Exp. Med. 2001, 193(1):13-25.
69. Ishikawa T., Harada T., Kubota T., Aso T. Testosterone inhibits matrix metalloproteinase-1 production in human endometrial stromal cells in vitro. Reproduction 2007, 133(6):1233-1239.
70. Iwahashi M., Muragaki Y., Ooshima A., Yamoto M., Nakano R. Alterations in distribution and composition of the extracellular matrix during decidualization of the human endometrium. J. Reprod. Fertil. 1996, 108(1):147-155.
71. Jabbour H.N., Kelly R.W., Fraser H.M., Critchley H.O. Endocrine regulation of menstruation. Endocr. Rev. 2006, 27(1):17-46.
72. Jokimaa V., Oksjoki S., Kujari H., Vuorio E., Anttila L. Expression patterns of cathepsins B, H, K, L and S in the human endometrium. Mol. Hum. Reprod. 2001, 7(1):73-78.
73. Jones M.C., Fusi L., Higham J.H., Abdel-Hafiz H., Horwitz K.B., Lam E.W., Brosens J.J. Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone. Proc. Natl. Acad. Sci. USA 2006, 103(44):16272-16277.
74. Jones R.K., Searle R.F., Bulmer J.N. Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum. Reprod. 1998, 13(12):3496-3502.
75. Jones R.L., Hannan N.J., Kaitu'u T.J., Zhang J., Salamonsen L.A. Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J. Clin. Endocrinol. Metab. 2004, 89(12):6155-6167.
76. Jones R.L., Kelly R.W., Critchley H.O. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum. Reprod. 1997, 12(6):1300-1306.
77. Jones R.L., Stoikos C., Findlay J.K., Salamonsen L.A. TGF-{beta} superfamily expression and actions in the endometrium and placenta. Reproduction 2006, 132(2):217-232.
78. Kaitu'u-Lino T.J., Phillips D.J., Morison N.B., Salamonsen L.A. A new role for activin in endometrial repair after menses. Endocrinology 2009, 150(4):1904-1911.
79. Kane N., Jones M., Brosens J.J., Saunders P.T., Kelly R.W., Critchley H.O. Transforming growth factor-beta1 attenuates expression of both the progesterone receptor and Dickkopf in differentiated human endometrial stromal cells. Mol. Endocrinol. 2008, 22(3):716-728.
80. Kaunitz, A.M., 2000. Menstruation: choosing whether...and when. Contraception 62(6), 277-284.
81. Kelly R.W., Illingworth P., Baldie G., Leask R., Brouwer S., Calder A.A. Progesterone control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition. Hum. Reprod. 1994, 9(2):253-258.
82. Kelly R.W., King A.E., Critchley H.O. Cytokine control in human endometrium. Reproduction 2001, 121(1):3-19.
83. Kitaya K., Yasuda J., Yagi I., Tada Y., Fushiki S., Honjo H. IL-15 expression at human endometrium and decidua. Biol. Reprod. 2000, 63(3):683-687.
84. Kjeldsen L., Sengelov H., Lollike K., Nielsen M.H., Borregaard N. Isolation and characterization of gelatinase granules from human neutrophils. Blood 1994, 83(6):1640-1649.
85. Koh S.C., Wong P.C., Yuen R., Chua S.E., Ng B.L., Ratnam S.S. Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle. J. Reprod. Fertil. 1992, 96(2):407-413.
86. Kokorine I., Marbaix E., Henriet P., Okada Y., Donnez J., Eeckhout Y., Courtoy P.J. Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium. J. Cell Sci. 1996, 109:2151-2160.
87. Koks C.A., Groothuis P.G., Slaats P., Dunselman G.A., de Goeij A.F., Evers J.L. Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid. Fertil. Steril. 2000, 73(3):604-612.
88. Koolwijk P., Kapiteijn K., Molenaar B., van Spronsen E., van der Vecht B., Helmerhorst F.M., van Hinsbergh V.W. Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium. J. Clin. Endocrinol. Metab. 2001, 86(7):3359-3367.
89. Kraus W.L., Weis K.E., Katzenellenbogen B.S. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol. Cell. Biol. 1995, 15(4):1847-1857.
90. Krietsch T., Fernandes M.S., Kero J., Losel R., Heyens M., Lam E.W., Huhtaniemi I., Brosens J.J., Gellersen B. Human homologs of the putative G protein-coupled membrane progestin receptors (mPRalpha, beta, and gamma) localize to the endoplasmic reticulum and are not activated by progesterone. Mol. Endocrinol. 2006, 20(12):3146-3164.
91. Kuokkanen S., Chen B., Ojalvo L., Benard L., Santoro N., Pollard J.W. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol. Reprod. 2010, 82(4):791-801.
92. Labied S., Galant C., Nisolle M., Ravet S., Munaut C., Marbaix E., Foidart J.M., Frankenne F. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time. Hum. Reprod. 2009, 24(1):113-121.
93. Labied S., Kajihara T., Madureira P.A., Fusi L., Jones M.C., Higham J.M., Varshochi R., Francis J.M., Zoumpoulidou G., Essafi A., Fernandez de Mattos S., Lam E.W., Brosens J.J. Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium. Mol. Endocrinol. 2006, 20(1):35-44.
94. Lau T.M., Affandi B., Rogers P.A. Immunohistochemical detection of cathepsin D in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Mol. Hum. Reprod. 1996, 2(4):233-237.
95. Lecce G., Meduri G., Ancelin M., Bergeron C., Perrot-Applanat M. Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J. Clin. Endocrinol. Metab. 2001, 86(3):1379-1386.
96. Lessey B.A. Fine tuning of endometrial function by estrogen and progesterone through microRNAs. Biol. Reprod. 2010, 82(4):653-655.
97. Leung P.H., Salamonsen L.A., Findlay J.K. Immunolocalization of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum. Reprod. 1998, 13(12):3469-3477.
98. Li A., Felix J.C., Hao J., Minoo P., Jain J.K. Menstrual-like breakdown and apoptosis in human endometrial explants. Hum. Reprod. 2005, 20(6):1709-1719.
99. Lobo S.C., Huang S.T., Germeyer A., Dosiou C., Vo K.C., Tulac S., Nayak N.R., Giudice L.C. The immune environment in human endometrium during the window of implantation. Am. J. Reprod. Immunol. 2004, 52(4):244-251.
100. Lumsden M.A., Kelly R.W., Abel M.H., Baird D.T. The concentrations of prostaglandins in endometrium during the menstrual cycle in women with measured menstrual blood loss. Prostaglandins Leukot. Med. 1986, 23(2-3):217-227.
101. Maentausta O., Svalander P., Danielsson K.G., Bygdeman M., Vihko R. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. J. Clin. Endocrinol. Metab. 1993, 77(4):913-918.
102. Malik S., Day K., Perrault I., Charnock-Jones D.S., Smith S.K. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia. Hum. Reprod. 2006, 21(8):2158-2166.
103. Marbaix E., Donnez J., Courtoy P.J., Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. USA 1992, 89(24):11789-11793.
104. Marbaix, E., Kokorine, I., Donnez, J., Eeckhout, Y., and Courtoy, P.J., 1996a. Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation. Hum. Reprod. 11 (Suppl. 2), 134-143.
105. Marbaix E., Kokorine I., Moulin P., Donnez J., Eeckhout Y., Courtoy P.J. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc. Natl. Acad. Sci. USA 1996, 93(17):9120-9125.
106. Markee J.E. Menstruation in intraocular endometrial transplants in the Rhesus monkey. Am. J. Obstet. Gynecol. 1978, 131(5):558-559.
107. Marsh, M.M., Findlay, J.K., Salamonsen, L.A., 1996. Endothelin and menstruation. Hum. Reprod. 11(Suppl. 2), 83-89.
108. Massafra C., De Felice C., Agnusdei D.P., Gioia D., Bagnoli F. Androgens and osteocalcin during the menstrual cycle. J. Clin. Endocrinol. Metab. 1999, 84(3):971-974.
109. Matrisian L.M. The matrix-degrading metalloproteinases. BioEssays 1992, 14(7):455-463.
110. Maudelonde T., Martinez P., Brouillet J.P., Laffargue F., Pages A., Rochefort H. Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J. Clin. Endocrinol. Metab. 1990, 70(1):115-121.
111. Maybin J.A., Hirani N., Jabbour H.N., Critchley H.O. Novel roles for hypoxia and prostaglandin e(2) in the regulation of IL-8 during endometrial repair. Am. J. Pathol. 2011, 178(3):1245-1256.
112. McDonald S.E., Henderson T.A., Gomez-Sanchez C.E., Critchley H.O., Mason J.I. 11Beta-hydroxysteroid dehydrogenases in human endometrium. Mol. Cell. Endocrinol. 2006, 248(1-2):72-78.
113. McLennan C.E., Rydell A.H. Extent of endometrial shedding during normal menstruation. Obstet. Gynecol. 1965, 26(5):605-621.
114. Mignatti P., Rifkin D.B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 1993, 73(1):161-195.
115. Minarowska A., Minarowski L., Karwowska A., Gacko M. Regulatory role of cathepsin D in apoptosis. Folia Histochem. Cytobiol. 2007, 45(3):159-163.
116. Mokhtar N.M., Cheng C.W., Cook E., Bielby H., Smith S.K., Charnock-Jones D.S. Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium. Mol. Hum. Reprod. 2010, 16(3):170-177.
117. Mote P.A., Balleine R.L., McGowan E.M., Clarke C.L. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J. Clin. Endocrinol. Metab. 1999, 84(8):2963-2971.
118. Mulac-Jericevic B., Conneely O.M. Reproductive tissue selective actions of progesterone receptors. Reproduction 2004, 128(2):139-146.
119. Munro, M.G., Critchley, H.O., Fraser, I.S., 2011. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil. Steril. 95(7), 2204-8, 2208 e1-2208 e3.
120. Murphy G., Nagase H. Progress in matrix metalloproteinase research. Mol. Aspects Med. 2008, 29(5):290-308.
121. Murphy G., Ward R., Gavrilovic J., Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix 1992, (Suppl. 1):224-230.
122. Mustonen M.V., Isomaa V.V., Vaskivuo T., Tapanainen J., Poutanen M.H., Stenback F., Vihko R.K., Vihko P.T. Human 17 beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle. J. Clin. Endocrinol. Metab. 1998, 83(4):1319-1324.
123. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 2006, 69(3):562-573.
124. Nardulli A.M., Greene G.L., O'Malley B.W., Katzenellenbogen B.S. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988, 122(3):935-944.
125. Nardulli A.M., Katzenellenbogen B.S. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology 1988, 122(4):1532-1540.
126. Nogales-Ortiz, F., Puerta, J., Nogales Jr., F.F., 1978. The normal menstrual cycle. Chronology and mechanism of endometrial desquamation. Obstet. Gynecol. 51(3), 259-264.
127. Nordengren J., Pilka R., Noskova V., Ehinger A., Domanski H., Andersson C., Hoyer-Hansen G., Hansson S.R., Casslen B. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol. Hum. Reprod. 2004, 10(9):655-663.
128. Ohbuchi H., Nagai K., Yamaguchi M., Ikenoue T., Mori N., Kitamura K., Araki S., Toshimori K. Endothelin-1 and big endothelin-1 increase in human endometrium during menstruation. Am. J. Obstet. Gynecol. 1995, 173(5):1483-1490.
129. Okada H., Nakajima T., Sanezumi M., Ikuta A., Yasuda K., Kanzaki H. Progesterone enhances interleukin-15 production in human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 2000, 85(12):4765-4770.
130. Okada S., Okada H., Sanezumi M., Nakajima T., Yasuda K., Kanzaki H. Expression of interleukin-15 in human endometrium and decidua. Mol. Hum. Reprod. 2000, 6(1):75-80.
131. Otsuki Y. Apoptosis in human endometrium: apoptotic detection methods and signaling. Med. Electron. Microsc. 2001, 34(3):166-173.
132. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 2007, 8(3):221-233.
133. Pan Q., Chegini N. MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin. Reprod. Med. 2008, 26(6):479-493.
134. Pan Q., Luo X., Toloubeydokhti T., Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol. Hum. Reprod. 2007, 13(11):797-806.
135. Perrot-Applanat M., Groyer-Picard M.T., Garcia E., Lorenzo F., Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 1988, 123(3):1511-1519.
136. Philippeaux M.M., Piguet P.F. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am. J. Pathol. 1993, 143(2):480-486.
137. Pilka R., Noskova V., Domanski H., Andersson C., Hansson S., Casslen B. Endometrial TIMP-4 mRNA is expressed in the stroma, while TIMP-4 protein accumulates in the epithelium and is released to the uterine fluid. Mol. Hum. Reprod. 2006, 12(8):497-503.
138. Pilka R., Whatling C., Domanski H., Hansson S., Eriksson P., Casslen B. Epithelial expression of matrix metalloproteinase-26 is elevated at mid-cycle in the human endometrium. Mol. Hum. Reprod. 2003, 9(5):271-277.
139. Popovici R.M., Irwin J.C., Giaccia A.J., Giudice L.C. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. J. Clin. Endocrinol. Metab. 1999, 84(6):2245-2248.
140. Popovici R.M., Kao L.C., Giudice L.C. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinology 2000, 141(9):3510-3513.
141. Press, M.F., Udove, J.A., Greene, G.L., 1988. Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am. J. Pathol. 131(1), 112-124.
142. Pretto C.M., Gaide Chevronnay H.P., Cornet P.B., Galant C., Delvaux D., Courtoy P.J., Marbaix E., Henriet P. Production of interleukin-1alpha by human endometrial stromal cells is triggered during menses and dysfunctional bleeding and is induced in culture by epithelial interleukin-1alpha released upon ovarian steroids withdrawal. J. Clin. Endocrinol. Metab. 2008, 93(10):4126-4134.
143. Prudovsky I., Mandinova A., Soldi R., Bagala C., Graziani I., Landriscina M., Tarantini F., Duarte M., Bellum S., Doherty H., Maciag T. The non-classical export routes: FGF1 and IL-1alpha point the way. J. Cell Sci. 2003, 116(Pt. 24):4871-4881.
144. Rawdanowicz T.J., Hampton A.L., Nagase H., Woolley D.E., Salamonsen L.A. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J. Clin. Endocrinol. Metab. 1994, 79(2):530-536.
145. Rees M.C., Anderson A.B., Demers L.M., Turnbull A.C. Endometrial and myometrial prostaglandin release during the menstrual cycle in relation to menstrual blood loss. J. Clin. Endocrinol. Metab. 1984, 58(5):813-818.
146. Rigot V., Marbaix E., Lemoine P., Courtoy P.J., Eeckhout Y. In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo. Biochem. J. 2001, 358(Pt 1):275-280.
147. Robinson-Rechavi M., Escriva Garcia H., Laudet V. The nuclear receptor superfamily. J. Cell Sci. 2003, 116(Pt. 4):585-586.
148. Rodgers W.H., Matrisian L.M., Giudice L.C., Dsupin B., Cannon P., Svitek C., Gorstein F., Osteen K.G. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest. 1994, 94(3):946-953.
149. Roy-Beaudry M., Martel-Pelletier J., Pelletier J.P., M'Barek K.N., Christgau S., Shipkolye F., Moldovan F. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction. Arthritis Rheum. 2003, 48(10):2855-2864.
150. Salamonsen L.A., Butt A.R., Macpherson A.M., Rogers P.A., Findlay J.K. Immunolocalization of the vasoconstrictor endothelin in human endometrium during the menstrual cycle and in umbilical cord at birth. Am. J. Obstet. Gynecol. 1992, 167(1):163-167.
151. Salamonsen L.A., Marsh M.M., Findlay J.K. Endometrial endothelin: regulator of uterine bleeding and endometrial repair. Clin. Exp. Pharmacol. Physiol. 1999, 26(2):154-157.
152. Salamonsen L.A., Woolley D.E. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J. Reprod. Immunol. 1999, 44(1-2):1-27.
153. Salamonsen L.A., Zhang J., Brasted M. Leukocyte networks and human endometrial remodelling. J. Reprod. Immunol. 2002, 57(1-2):95-108.
154. Schmitt M., Goretzki L., Janicke F., Calvete J., Eulitz M., Kobayashi H., Chucholowski N., Graeff H. Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer. Biomed. Biochim. Acta 1991, 50(4-6):731-741.
155. Schroen D.J., Brinckerhoff C.E. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Expr. 1996, 6(4):197-207.
156. Selvais C., Gaide Chevronnay H.P., Lemoine P., Dedieu S., Henriet P., Courtoy P.J., Marbaix E., Emonard H. Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation. Endocrinology 2009, 150(8):3792-3799.
157. Sharkey A.M., Day K., McPherson A., Malik S., Licence D., Smith S.K., Charnock-Jones D.S. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J. Clin. Endocrinol. Metab. 2000, 85(1):402-409.
158. Shiozawa T., Shih H.C., Miyamoto T., Feng Y.Z., Uchikawa J., Itoh K., Konishi I. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J. Clin. Endocrinol. Metab. 2003, 88(2):871-878.
159. Simoncini T., Genazzani A.R. Non-genomic actions of sex steroid hormones. Eur. J. Endocrinol. 2003, 148(3):281-292.
160. Singer C.F., Marbaix E., Kokorine I., Lemoine P., Donnez J., Eeckhout Y., Courtoy P.J. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids. Proc. Natl. Acad. Sci. USA 1997, 94(19):10341-10345.
161. Singer C.F., Marbaix E., Lemoine P., Courtoy P.J., Eeckhout Y. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur. J. Biochem. 1999, 259(1-2):40-45.
162. Smith O.P., Jabbour H.N., Critchley H.O. Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation. Hum. Reprod. 2007, 22(5):1450-1456.
163. Snijders M.P., de Goeij A.F., Debets-Te Baerts M.J., Rousch M.J., Koudstaal J., Bosman F.T. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J. Reprod. Fertil. 1992, 94(2):363-371.
164. Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., Goldberg, G.I., 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270(10), 5331-5338.
165. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol. Hum. Reprod. 1996, 2(2):77-92.
166. Tabibzadeh S., Zupi E., Babaknia A., Liu R., Marconi D., Romanini C. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. Hum. Reprod. 1995, 10(2):277-286.
167. Takano M., Lu Z., Goto T., Fusi L., Higham J., Francis J., Withey A., Hardt J., Cloke B., Stavropoulou A.V., Ishihara O., Lam E.W., Unterman T.G., Brosens J.J., Kim J.J. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. Mol. Endocrinol. 2007, 21(10):2334-2349.
168. Talbi S., Hamilton A.E., Vo K.C., Tulac S., Overgaard M.T., Dosiou C., Le Shay N., Nezhat C.N., Kempson R., Lessey B.A., Nayak N.R., Giudice L.C. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006, 147(3):1097-1121.
169. Tao X.J., Tilly K.I., Maravei D.V., Shifren J.L., Krajewski S., Reed J.C., Tilly J.L., Isaacson K.B. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J. Clin. Endocrinol. Metab. 1997, 82(8):2738-2746.
170. Thomas P. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front. Neuroendocrinol. 2008, 29(2):292-312.
171. Toloubeydokhti T., Pan Q., Luo X., Bukulmez O., Chegini N. The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod. Sci. 2008, 15(10):993-1001.
172. Vaskivuo T.E., Stenback F., Karhumaa P., Risteli J., Dunkel L., Tapanainen J.S. Apoptosis and apoptosis-related proteins in human endometrium. Mol. Cell. Endocrinol. 2000, 165(1-2):75-83.
173. Vassilev V., Pretto C.M., Cornet P.B., Delvaux D., Eeckhout Y., Courtoy P.J., Marbaix E., Henriet P. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo. J. Clin. Endocrinol. Metab. 2005, 90(10):5848-5857.
174. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 1993, 7(10):1244-1255.
175. Verma S., Hiby S.E., Loke Y.W., King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol. Reprod. 2000, 62(4):959-968.
176. Wei L.L., Gonzalez-Aller C., Wood W.M., Miller L.A., Horwitz K.B. 5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C" -receptor and unique A-receptor messages. Mol. Endocrinol. 1990, 4(12):1833-1840.
177. Wieser F., Schneeberger C., Hudelist G., Singer C., Kurz C., Nagele F., Gruber C., Huber J.C., Tschugguel W. Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation. Mol. Hum. Reprod. 2002, 8(7):644-650.
178. Wood J.C., Williams E.A., Barley V.L., Cowdell R.H. The activity of hydrolytic enzymes in the human endometrium during the menstrual cycle. J. Obstet. Gynaecol. Br. Commonw. 1969, 76(8):724-728.
179. Zhang J., Salamonsen L.A. Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation. Hum. Reprod. 2002, 17(2):265-274.
180. Zhang J., Salamonsen L.A. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J. Clin. Endocrinol. Metab. 2002, 87(5):2346-2351.